Challenging Established Paradigms in Cancer


  • Sol J. Barer, PhD, SJBarer Consulting LLC


  • Rajesh Chopra, MD, PhD, Corporate VP, Translational and Early Drug Development, Celgene Corporation
  • Giulio Draetta, MD, PhD, Director, Institute for Applied Cancer Science, Professor, Genomic Medicine, MD Anderson Cancer Center
  • Tak Mak, PhD, University Professor, Ontario Cancer Institute, University of Toronto
  • Neal Rosen, MD, PhD, Director, Center for Mechanism-Based Therapeutics, Memorial Sloan-Kettering Cancer Center